- Short Report
- Published:
Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line
- Miki Ohira1 na1,
- Hajime Kageyama1 na1,
- Motohiro Mihara1,
- Shigeyuki Furuta1,
- Taiichi Machida1,
- Tomotane Shishikura1,
- Hajime Takayasu1,
- Ashraful Islam1,
- Yohko Nakamura1,
- Masato Takahashi1,
- Nobumoto Tomioka1,
- Shigeru Sakiyama1,
- Yasuhiko Kaneko2,
- Atsushi Toyoda3,
- Masahira Hattori3,
- Yoshiyuki Sakaki4,
- Misao Ohki5,
- Akira Horii6,
- Eiichi Soeda7,
- Johji Inazawa8,
- Naohiko Seki9,
- Hidekazu Kuma10,
- Iwao Nozawa10 &
- …
- Akira Nakagawara1
Oncogenevolume 19, pages4302–4307 (2000)Cite this article
840Accesses
72Citations
9Altmetric
Abstract
Loss of heterozygosity of the distal region of chromosome 1p where tumor suppressor gene(s) might harbor is frequently observed in many human cancers including neuroblastoma (NBL) withMYCN amplification and poor prognosis. We have identified for the first time a homozygously deleted region at the markerD1S244 within the smallest region of overlap at 1p36.2-p36.3 in two NBL cell lines, NB-1 and NB-C201 (MASS-NB-SCH1), although our genotyping has suggested the possibility that both lines are derived from the same origin. The 800-kb PAC contig covering the entire region of homozygous deletion was made and partially sequenced (about 60%). The estimated length of the deleted region was 500 kb. We have, thus far, identified six genes within the region which include three known genes (DFF45,PGD, andCORT) as well as three other genes which have been reported during processing our present project for the last 3½ years (HDNB1/UFD2,KIAA0591F/KIF1B-β, andPEX14). They include the genes related to apoptosis, glucose metabolism, ubiquitin-proteasome pathway, a neuronal microtubule-associated motor molecule and biogenesis of peroxisome. At least three genes (HDNB1/UFD2,KIAA0591F/KIF1B-β, andPEX14) were differentially expressed at high levels in favorable and at low levels in unfavorable subsets of primary neuroblastoma. Since the 1p distal region is reported to be imprinted, those differentially expressed genes could be the new members of the candidate NBL suppressor, although RT-PCR-SSCP analysis has demonstrated infrequent mutation of the genes so far identified. Full-sequencing and gene prediction for the region of homozygous deletion would elucidate more detailed structure of this region and might lead to discovery of additional candidate genes.
This is a preview of subscription content,access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
¥40,000 per year
only ¥800 per issue
Prices may be subject to local taxes which are calculated during checkout



Similar content being viewed by others
References
Amler LC, Corvi R, Praml C, Savelyeva L, Le Paslier D and Schwab M. . 1995Oncogene10: 1095–1101.
Bolande RP. . 1974Hum. Pathol.5: 409–429.
Brodeur GM, Seeger RC, Schwab M, Varmus HE and Bishop JM. . 1984Science224: 1121–1124.
Carling T, Imanishi Y, Gaz RD and Arnold A. . 1999Int. J. Cancer83: 80–82.
Caron H, van Sluis P, van Hoeve M, de Kraker J, Bras J, Slater R, Mannens M, Voute PA, Westerveld A and Versteeg R. . 1993Nat. Genet.4: 187–190.
Caron H. . 1995Med. Pediatr. Oncol.24: 215–221.
Cheng NC, Van Roy N, Chan A, Beitsma M, Westerveld A, Speleman F and Versteeg R. . 1995Oncogene10: 291–297.
de Lecea L, Ruiz-Lozano P, Danielson PE, Peelle-Kirley J, Foye PE, Frankel WN and Sutcliffe JG. . 1997Genomics42: 499–506.
Diccianni MB, Chau LS, Batova A, Vu TQ and Yu AL. . 1996Cancer Lett.104: 183–192.
Dracopoli NC, Stanger BZ, Lager M and Housman DE. . 1988Genomics3: 124–128.
Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A and Nagata S. . 1998Nature391: 43–50.
Enomoto H, Ozaki T, Takahashi E, Nomura N, Tabata S, Takahashi H, Ohnuma N, Tanabe M, Iwai J, Yoshida H, Matsunaga T and Sakiyama S. . 1994Oncogene9: 2785–2791.
Fukusumi S, Kitada C, Takekawa S, Kizawa H, Sakamoto J, Miyamoto M, Hinuma S, Kitano K and Fujino M. . 1997Biochem. Biophys. Res. Commun.232: 157–163.
Hattori M, Tsukahara F, Furuhata Y, Tanahashi H, Hirose M, Saito M, Tsukuni S and Sakaki Y. . 1997Nucleic Acids Res.25: 1802–1808.
He L, Yu JX, Liu L, Buyse IM, Wang MS, Yang QC, Nakagawara A, Brodeur GM, Shi YE and Huang S. . 1998Cancer Res.58: 4238–4244.
Hiraiwa H, Hamazaki M, Takata A, Kikuchi H and Hata J. . 1997Cancer79: 2036–2044.
Ichimiya S, Nimura Y, Kageyama H, Takada N, Sunahara M, Shishikura T, Nakamura Y, Sakiyama S, Seki N, Ohira M, Kaneko Y, McKeon F, Caput D and Nakagawara A. . 1999Oncogene18: 1061–1066.
Imashuku S, Inui A, Nakamura T, Tanaka J and Miyake S. . 1973J. Clin. Endocrinol. Metab.36: 931–936.
Ioannou PA, Amemiya CT, Garnes J, Kroisel PM, Shizuya H, Chen C, Batzer MA and de Jong PJ. . 1994Nat. Genet.6: 84–89.
Johnson ES, Ma PC, Ota IM and Varshavsky A. . 1995J. Biol. Chem.270: 17442–17456.
Jones PA and Laird PW. . 1999Nature Genet.21: 163–167.
Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F and Caput D. . 1997Cell90: 809–819.
Knudson AG. . 1971Proc. Natl. Acad. Sci. USA68: 820–823.
Koegl M, Hoppe T, Schlenker S, Ulrich HD, Mayer TU and Jentsch S. . 1999Cell96: 635–644.
Lahti JM, Valentine M, Xiang J, Jones B, Amann J, Grenet J, Richmond G, Look AT and Kidd VJ. . 1994Nat. Genet.7: 370–375.
Liu X, Zou H, Slaughter C and Wang X. . 1997Cell89: 175–184.
Martinsson T, Sjoberg RM, Hedborg F and Kogner P. . 1995Cancer Res.55: 5681–5686.
Martinsson T, Sjoberg RM, Hedborg F and Kogner P. . 1997Cancer Genet. Cytogenet.95: 183–189.
Nagai M, Ichimiya S, Ozaki T, Seki N, Mihara M, Furuta S, Ohira M, Tomioka N, Nomura N, Sakiyama S, Kubo O, Takakura K, Hori T and Nakagawara A. . 2000Int. J. Oncol.16: 907–916.
Nagase T, Ishikawa K, Miyajima N, Tanaka A, Kotani H, Nomura N and Ohara O. . 1998DNA Res.5: 31–39.
Nangaku M, Sato-Yoshitake R, Okada Y, Noda Y, Takemura R, Yamazaki H and Hirokawa N. . 1994Cell79: 1209–1220.
Pukatzki S, Tordilla N, Franke J and Kessin RH. . 1998J. Biol. Chem.273: 24131–24138.
Schleiermacher G, Peter M, Michon J, Hugot JP, Vielh P, Zucker JM, Magdelenat H, Thomas G and Delattre O. . 1994Genes Chromosomes Cancer10: 275–281.
Schwab M, Praml C and Amler LC. . 1996Genes Chromosomes Cancer16: 211–229.
Sunahara M, Ichimiya S, Nimura Y, Takada N, Sakiyama S, Sato Y, Todo S, Adachi W, Amano J and Nakagawara A. . 1998Int. J. Oncol.13: 319–323.
Takeda O, Homma C, Maseki N, Sakurai M, Kanda N, Schwab M, Nakamura Y and Kaneko Y. . 1994Genes Chromosomes Cancer10: 30–39.
Takemura R, Nakata T, Okada Y, Yamazaki H, Zhang Z and Hirokawa N. . 1996J. Neurosci.16: 31–35.
The I, Murthy AE, Hannigan GE, Jacoby LB, Menon AG, Gusella JF and Bernards A. . 1993Nat. Genet.3: 62–66.
Tsui SK, Chan JY, Waye MM, Fung KP and Lee CY. . 1996Biochem. Genet.34: 367–373.
White PS, Kaufman BA, Marshall HN and Brodeur GM. . 1993Genes Chromosomes Cancer7: 102–108.
White PS, Maris JM, Beltinger C, Sulman E, Marshall HN, Fujimori M, Kaufman BA, Biegel JA, Allen C, Hilliard C, Valentine MB, Look AT, Enomoto H, Sakiyama S and Brodeur GM. . 1995Proc. Natl. Acad. Sci. USA92: 5520–5524.
Will GK, Soukupova M, Hong X, Erdmann KS, Kiel JA, Dodt G, Kunau WH and Erdmann R. . 1999Mol. Cell Biol.19: 2265–2277.
Wise CA, Clines GA, Massa H, Trask BJ and Lovett M. . 1997Genome Res.7: 10–16.
Acknowledgements
The authors thank Drs S Ichimiya, Y Nimura, and N Takada for helpful discussions, to Drs M Nagai, M Naka, T Iijima and S Saitoh for experimental support, to Ms A Morohashi, N Sugimitsu, E Kojima for technical assistance. We are grateful to Drs M Hamazaki and H Hiraiwa for providing the cell line and useful discussion and Dr M Oshimura for giving the hybrid cells. The authors also thank the hospitals and institutes collaborating with the Japanese Neuroblastoma Study Group for providing surgical specimens.
This work was supported in part by a grant-in-aid from the Ministry of Health and Welfare for a New Comprehensive 10-year Strategy for Cancer Control, Japan, by a grant-in-aid from the Ministry of Education, Science, and Culture of Japan, and by a grant from Uehara Memorial Foundation.
Author information
Miki Ohira and Hajime Kageyama: M Ohira and H Kageyama contributed to this work
Authors and Affiliations
Division of Biochemistry, Chiba Cancer Center Research Institute, Chiba, 260-8717, Japan
Miki Ohira, Hajime Kageyama, Motohiro Mihara, Shigeyuki Furuta, Taiichi Machida, Tomotane Shishikura, Hajime Takayasu, Ashraful Islam, Yohko Nakamura, Masato Takahashi, Nobumoto Tomioka, Shigeru Sakiyama & Akira Nakagawara
Department of Cancer Chemotherapy, Saitama Cancer Center Hospital, Saitama, 362-0806, Japan
Yasuhiko Kaneko
RIKEN Genomic Sciences Center, Sagamihara, 228-8555, Kanagawa, Japan
Atsushi Toyoda & Masahira Hattori
Human Genome Center, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo, 108-8639, Japan
Yoshiyuki Sakaki
Cancer Genomics Division, National Cancer Center Research Institute, Chuoh-ku, Tokyo, 104-0045, Japan
Misao Ohki
Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, 980-8575, Japan
Akira Horii
RIKEN Gene Bank, Tsukuba, 305-0074, Ibaraki, Japan
Eiichi Soeda
Department of Molecular Cytogenetics, Division of Genetics, Medical Research Institute, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, 113-8519, Japan
Johji Inazawa
Biological Technology Laboratory, Helix Research Institute, Inc., Kisarazu, 292-0812, Chiba, Japan
Naohiko Seki
New Technology Development Department, Central Research Center, Hisamitsu Pharmaceutical Co., Inc., Tsukuba Research Laboratories, Tsukuba, 305-0856, Ibaraki, Japan
Hidekazu Kuma & Iwao Nozawa
- Miki Ohira
You can also search for this author inPubMed Google Scholar
- Hajime Kageyama
You can also search for this author inPubMed Google Scholar
- Motohiro Mihara
You can also search for this author inPubMed Google Scholar
- Shigeyuki Furuta
You can also search for this author inPubMed Google Scholar
- Taiichi Machida
You can also search for this author inPubMed Google Scholar
- Tomotane Shishikura
You can also search for this author inPubMed Google Scholar
- Hajime Takayasu
You can also search for this author inPubMed Google Scholar
- Ashraful Islam
You can also search for this author inPubMed Google Scholar
- Yohko Nakamura
You can also search for this author inPubMed Google Scholar
- Masato Takahashi
You can also search for this author inPubMed Google Scholar
- Nobumoto Tomioka
You can also search for this author inPubMed Google Scholar
- Shigeru Sakiyama
You can also search for this author inPubMed Google Scholar
- Yasuhiko Kaneko
You can also search for this author inPubMed Google Scholar
- Atsushi Toyoda
You can also search for this author inPubMed Google Scholar
- Masahira Hattori
You can also search for this author inPubMed Google Scholar
- Yoshiyuki Sakaki
You can also search for this author inPubMed Google Scholar
- Misao Ohki
You can also search for this author inPubMed Google Scholar
- Akira Horii
You can also search for this author inPubMed Google Scholar
- Eiichi Soeda
You can also search for this author inPubMed Google Scholar
- Johji Inazawa
You can also search for this author inPubMed Google Scholar
- Naohiko Seki
You can also search for this author inPubMed Google Scholar
- Hidekazu Kuma
You can also search for this author inPubMed Google Scholar
- Iwao Nozawa
You can also search for this author inPubMed Google Scholar
- Akira Nakagawara
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Ohira, M., Kageyama, H., Mihara, M.et al. Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line.Oncogene19, 4302–4307 (2000). https://doi.org/10.1038/sj.onc.1203786
Received:
Revised:
Accepted:
Published:
Issue Date:
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
Keywords
This article is cited by
Discovery, characterization and potential roles of a novel NF-YAx splice variant in human neuroblastoma
- Lucia Cappabianca
- Antonietta Rosella Farina
- Andrew Reay Mackay
Journal of Experimental & Clinical Cancer Research (2019)
Identification of novel susceptibility markers for the risk of overall breast cancer as well as subtypes defined by hormone receptor status in the Chinese population
- Zhiping Deng
- Hua Yang
- Hong Ren
Journal of Human Genetics (2016)
RUNX3 interacts with MYCN and facilitates protein degradation in neuroblastoma
- F Yu
- W Gao
- A Nakagawara
Oncogene (2014)
The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis
- Raquel Domingo-Fernandez
- Karen Watters
- Isabella Bray
Pediatric Surgery International (2013)
Leucine to proline substitution by SNP at position 197 in Caspase-9 gene expression leads to neuroblastoma: a bioinformatics analysis
- Arpita Kundu
- Susmita Bag
- Anand Anbarasu
3 Biotech (2013)